Calcium Folinate Injection 50 mg/5 mL vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

calcium folinate, Quantity: 10.8 mg/mL (Equivalent: calcium folinate, Qty 10 mg/mL; Equivalent: folinic acid, Qty 10 mg/mL)

Disponível em:

Hospira Australia Pty Ltd

DCI (Denominação Comum Internacional):

Calcium folinate

Forma farmacêutica:

Injection

Composição:

Excipient Ingredients: hydrochloric acid; water for injections; sodium chloride; sodium hydroxide

Via de administração:

Intramuscular, Intravenous Infusion

Unidades em pacote:

1 x 5 mL vial

Classe:

Medicine Listed (Export Only)

Tipo de prescrição:

(S1) This Schedule is intentionally blank

Indicações terapêuticas:

Calcium Leucovorin is indicated in:a) Neutralising the immediate toxic effects of folic acid antagonists, e.g. Methotrexate b) Calcium Leucovorin Rescue - a treatment technique using Calcium Leucovorin in conjunction with folic acid antagonists, e.g. Methotrexate, to minimise systemic toxicity. c) The treatment of megaloblastic anaemias due to sprue, nutritional deficiency, pregnancy, infancy, liver disease and malabsorption syndrome.

Resumo do produto:

Visual Identification: A clear, straw to pale yellow coloured solution, free from particulate matter; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Status de autorização:

Listed (Export Only)

Data de autorização:

2007-06-13